Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

In 2024, researchers developed a panel of sensors that can detect certain enzymes associated with lung cancer ... including aspartate aminotransaminase (AST), alanine aminotransferase (ALT), ...

Combing through scads of DNA, chemical structure, and functional data, researchers have created an AI-guided platform that ...

AST SpaceMobile customer Vodafone completed ... explained that the video call was placed from a "remote mountainous location in mid-Wales ... where there has never been mobile broadband before ...

The engineered enzymes had similar gene-editing efficiency and reduced immune responses compared to standard nucleases in mice. Appearing today in Nature Communications, the findings could help ...

Apple and Globalstar already offered a similar service. The new partnership may limit growth opportunities for both Globalstar and AST SpaceMobile. "Apple Inc. has been secretly working with ...

"We are excited to offer significantly lower upfront fees for rights to a leading CRISPR enzyme enabling therapeutic developers to de-risk their fundraising process, and making overall development ...

Readers may compare TMUS stock to AST SpaceMobile’s partners. Notably, both AT&T and Verizon have a high industry ranking of seventh and fourth, respectively. Although BCE scores strongly on ...

AST SpaceMobile (ASTS) announced an agreement for long-term access to up to 45 MHz of lower mid-band spectrum in the United States for direct-to-device satellite applications. This agreement, when ...

Three days after completing the course, his AST level was 9 times the ULN, ALT was 11 times the ULN, TB was 22 times the ULN, conjugated bilirubin was 15 times the ULN, and ALP was 6 times the ULN.

This agreement grants Synthego a global license to manufacture and distribute AstraZeneca's novel CRISPR gene editing enzyme, eSpOT-ON, recently published as engineered ePsCas9, to the worldwide ...